These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8491246)

  • 1. The effects of the COMT inhibitor nitecapone for one week on exercise haemodynamics and catecholamine disposition.
    Sundberg S; Scheinin M; Ojala-Karlsson P; Akkila J; Gordin A
    Eur J Clin Pharmacol; 1993; 44(3):287-90. PubMed ID: 8491246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone.
    Sundberg S; Scheinin M; Ojala-Karlsson P; Kaakkola S; Akkila J; Gordin A
    Clin Pharmacol Ther; 1990 Oct; 48(4):356-64. PubMed ID: 2225697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise.
    Sundberg S; Scheinin M; Illi A; Akkila J; Gordin A; Keränen T
    Br J Clin Pharmacol; 1993 Nov; 36(5):451-6. PubMed ID: 12959293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
    Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
    Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of L-dopa in healthy volunteers.
    Kaakkola S; Gordin A; Järvinen M; Wikberg T; Schultz E; Nissinen E; Pentikäinen PJ; Rita H
    Clin Neuropharmacol; 1990 Oct; 13(5):436-47. PubMed ID: 2272023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMT inhibition by high-dose entacapone does not affect hemodynamics but changes catecholamine metabolism in healthy volunteers at rest and during exercise.
    Illi A; Sundberg S; Koulu M; Scheinin M; Heinävaara S; Gordin A
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):582-8. PubMed ID: 7874370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMT inhibition with nitecapone does not affect the tyramine pressor response.
    Sundberg S; Gordin A
    Br J Clin Pharmacol; 1991 Jul; 32(1):130-2. PubMed ID: 1888633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous inhibition of catecholamine-O-methylation by entacapone and neuronal uptake by imipramine: lack of interactions.
    Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
    Eur J Clin Pharmacol; 1996; 51(3-4):273-6. PubMed ID: 9010698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone.
    Schultz E; Tarpila S; Bäckström AC; Gordin A; Nissinen E; Pohto P
    Eur J Clin Pharmacol; 1991; 40(6):577-80. PubMed ID: 1884738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nitecapone (OR-462) on the pharmacokinetics of levodopa and 3-O-methyldopa formation in cynomolgus monkeys.
    Cedarbaum JM; Léger G; Reches A; Guttman M
    Clin Neuropharmacol; 1990 Dec; 13(6):544-52. PubMed ID: 2276119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraneuronal enzymatic degradation of myocardial interstitial norepinephrine in the ischemic region.
    Fujii T; Yamazaki T; Akiyama T; Sano S; Mori H
    Cardiovasc Res; 2004 Oct; 64(1):125-31. PubMed ID: 15364620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism and positron emission tomography after catechol-O-methyltransferase inhibition in normal and hemiparkinsonian monkeys.
    Miletich RS; Comi G; Bankiewicz K; Plunkett R; Adams R; Di Chiro G; Kopin IJ
    Brain Res; 1993 Oct; 626(1-2):1-13. PubMed ID: 8281420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone.
    Iijima H; Takebe K; Suzuki M; Kobayashi H; Takamiya T; Saito H; Niwa N; Kuwada-Kusunose T
    Chem Pharm Bull (Tokyo); 2020; 68(5):447-451. PubMed ID: 32378542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase.
    Scheinin M; Illi A; Koulu M; Ojala-Karlsson P
    Adv Pharmacol; 1998; 42():367-70. PubMed ID: 9327918
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of nisoldipine on stress-induced changes in haemodynamics and plasma catecholamines in normotensives and hypertensives.
    Ludwig J; Gerhardt T; Halbrügge T; Walter J; Heidbreder E; Graefe KH
    J Hum Hypertens; 1990 Dec; 4(6):693-701. PubMed ID: 2096212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of catechol-O-methyltransferase sensitize mice to pain.
    Kambur O; Talka R; Ansah OB; Kontinen VK; Pertovaara A; Kalso E; Männistö PT
    Br J Pharmacol; 2010 Dec; 161(7):1553-65. PubMed ID: 20726980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds.
    Flemström G; Säfsten B; Jedstedt G
    Gastroenterology; 1993 Mar; 104(3):825-33. PubMed ID: 8095035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of entacapone on the disposition and hemodynamic effects of intravenous isoproterenol and epinephrine.
    Illi A; Sundberg S; Ojala-Karlsson P; Korhonen P; Scheinin M; Gordin A
    Clin Pharmacol Ther; 1995 Aug; 58(2):221-7. PubMed ID: 7648772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA.
    Doudet DJ; Chan GL; Holden JE; Pate BD; Morrison KS; Calne DB; Ruth TJ
    Eur J Pharmacol; 1997 Sep; 334(1):31-8. PubMed ID: 9346324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.
    Nissinen E; Lindén IB; Schultz E; Kaakkola S; Männistö PT; Pohto P
    Eur J Pharmacol; 1988 Aug; 153(2-3):263-9. PubMed ID: 3181288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.